Humacyte’s bioengineered bypass vessel gets first human test
Humacyte opens a ten-patient trial of an off-the-shelf graft meant to spare bypass patients a vein taken from the leg. Before a surgeon can bypass a blocked heart artery, somebody has to supply the replacement pipe. Usually that means cutting a vein out of the patient’s own leg. Humacyte, a North Ca

<p>Humacyte opens a ten-patient trial of an off-the-shelf graft meant to spare bypass patients a vein taken from the leg. Before a surgeon can bypass a blocked heart artery, somebody has to supply the replacement pipe. Usually that means cutting a vein out of the patient’s own leg. Humacyte, a North Ca</p>